Related Experiment Video
Updated: Apr 28, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
17.7K
Dendritic cells transduced with CPEB4 induced antitumor immune response
Wei Peng1, Zhang Nan2, Yongping Liu3
1Department of Orthopaedics, 309th Hospital of PLA, Beijing 100091, China.
Experimental and Molecular Pathology
|June 15, 2014
Summary
Modified dendritic cells (DCs) expressing Cytoplasmic polyadenylation element binding protein 4 (CPEB4) effectively induced anti-tumor immunity against glioma cells in mice, suggesting potential as a novel cancer vaccine.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Glioblastoma (GBM) necessitates novel therapeutic strategies due to its aggressive nature.
- Cytoplasmic polyadenylation element binding protein 4 (CPEB4) has emerged as a potential therapeutic target for GBM.
- Immunologic approaches are being explored for tumor cell elimination.
Purpose of the Study:
- To investigate the anti-tumor immune response induced by dendritic cells (DCs) transduced with CPEB4 in vivo.
- To evaluate the therapeutic potential of CPEB4-modified DCs as a cancer vaccine against glioma.
Main Methods:
- Dendritic cells (DCs) were transduced with recombinant adenovirus encoding CPEB4.
- The study assessed the induction of specific cytotoxic T lymphocytes (CTLs) and IFN-γ secreting T-cells in mice.
- Mice were challenged with glioma cells to evaluate the protective effects of the modified DCs.
Main Results:
- CPEB4-transduced DCs successfully induced specific CTLs that lysed glioma cells.
- An increased number of IFN-γ secreting T-cells was observed in treated mice.
- Modified DCs demonstrated significant protection against lethal glioma challenges, reduced tumor growth, and extended lifespan.
Conclusions:
- DCs transduced with CPEB4 can elicit potent anti-tumor immunity against glioma.
- CPEB4-modified DCs hold promise as an effective tumor vaccine for clinical applications in glioblastoma treatment.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K